55,410€
0,76%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co
Bid:
Ask:
Anlagetrends der Bristol-Myers Squibb Co Aktie
Krebs-Immuntherapie
Biotechnologiekonzern forscht und entwickelt u.a. an Krebsimmuntherapieansätzen
Bristol-Myers Squibb Co gehört zu den Prime Aktien im Anlagetrend Krebs-Immuntherapie
Sektor: Medizin / Pharmaunternehmen
| Abbott Laboratories | - | 87,29€ | -1,63 % | ||
| ABBVIE | 3 | 231,20€ | -0,64 % | ||
| Agile Therapeutics | - | 0,30$ | -78,42 % | ||
| Akorn Inc. | - | - | - | ||
| Alcon | - | 64,60$ | -1,28 % | ||
| ASTRAZENECA DL-,25 SP.ADR | 7 | 92,83$ | 0,26 % | ||
| AstraZeneca PLC | 7 | 142,65€ | -1,72 % | ||
| Baxter International | 1 | 21,22€ | 1,53 % | ||
| BAYER AG NA O.N. | 2 | 47,76€ | -2,29 % | ||
| BIOTEST AG VZ O.N. | - | 29,50€ | -0,67 % | ||
| Bristol-Myers Squibb Co | 1 | 55,12€ | -0,68 % | ||
| Cumberland Pharmaceuticals | - | 7,83$ | 2,35 % | ||
| DERMAPHARM HLDG INH O.N. | - | 39,18€ | -0,32 % | ||
| Eagle Pharmaceuticals | - | 2,34$ | -34,27 % | ||
| Eli Lilly & Co | 3 | 1.023,80€ | -2,07 % | ||
| Endo International PLC | - | 0,47$ | 60,41 % | ||
| GRIFOLS SA INH. A EO-,25 | - | 9,54€ | 0,56 % | ||
| GSK plc | - | 44,32$ | 25,41 % | ||
| GSK PLC LS-,25 | - | 16,77€ | -17,24 % | ||
| HEIDELBERG PHARMA AG O.N. | - | 2,36€ | -0,63 % | ||
| Johnson & Johnson | 1 | 234,00€ | -0,74 % | ||
| Lannett Co. Inc. | - | 0,65$ | -3,86 % | ||
| Merck & Co | 2 | 128,40€ | -2,49 % | ||
| Nature's Sunshine Products | - | 12,69$ | -0,55 % | ||
| Novartis AG | - | 125,50€ | -1,57 % | ||
| NOVARTIS NAM. SF 0,49 | - | 118,98CHF | -1,61 % | ||
| Novo-Nordisk A/S | - | 33,47€ | -0,86 % | ||
| Pfizer | 2 | 25,20€ | -0,40 % | ||
| ROCHE HLDG AG INH. SF 1 | - | 361,99CHF | -0,22 % | ||
| Rockwell Medical Inc | - | 8,48$ | -2,19 % | ||
| Sanofi ADS | - | 36,30€ | 0,28 % | ||
| SANOFI SA INHABER EO 2 | - | 72,86€ | 1,94 % | ||
| Taro Pharmaceutical Industries Ltd | - | 42,97$ | 0,00 % | ||
| TEVA PHARMACEUT. SP.ADR | - | 31,95€ | 1,11 % | ||
| ZOETIS | - | 61,68€ | -0,77 % | ||